A retrospective study of SSRI treatment in adolescent anorexia nervosa: Insufficient evidence for efficacy

Journal of Psychiatric Research

Volumn 39, Issue 3, 2005, Pages 303-310

  Holtkamp, K ^a,c   Konrad, K ^a   Kaiser, N ^a   Ploenes, Y ^a   Heussen, N ^a   Grzella, I ^b   Herpertz Dahlmann, B ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Orthopaedic Department   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Adolescents; Anorexia nervosa; BMI; Depression; Obsessive compulsive; Selective serotonin reuptake inhibitor

Indexed keywords

FLUOXETINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; AGITATION; ANALYSIS OF VARIANCE; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMORBIDITY; DEPRESSION; DRUG EFFICACY; EATING; EATING DISORDER; FEMALE; FOLLOW UP; HUMAN; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RESTLESSNESS; RETROSPECTIVE STUDY; SIDE EFFECT;

EID: 13844267462     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2004.08.001     Document Type: Article

References (37)

1. E. Attia, C. Haiman, B.T. Walsh, and S.R. Flater Does fluoxetine augment the inpatient treatment of anorexia nervosa? American Journal of Psychiatry 155 1998 548 551
2. G.J. Emslie, J.H. Heiligenstein, K.D. Wagner, S.L. Hoog, D.E. Ernest, and E. Brown Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial Journal of the American Academy of Child and Adolescent Psychiatry 41 2002 1205 1215
3. S. Fassino, P. Leombruni, G. Daga, A. Brustolin, G. Migliaretti, and F. Cavallo Efficacy of citalopram in anorexia nervosa: a pilot study European Neuropsychopharmacology 12 2002 453 459
4. C.P. Ferguson, M.C. La Via, P.J. Crossan, and W.H. Kaye Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa? International Journal of Eating Disorders 25 1999 11 17
5. M.M. Fichter, and W. Keeser The anorexia nervosa inventory for self-rating (ANIS) (author's transl) Archir für Psychiatric und Nervenkrankheiten 228 1980 67 89
6. M.M. Fichter, S. Herpertz, N. Quadflieg, and B. Herpertz-Dahlmann Structured interview for anorexic and Bulimic disorders for DSM-IV and ICD-10: updated (third) revision International Journal of Eating Disorders 24 3 1998 227 249
7. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. Archives of General Psychiatry 1992;49:139-47
8. G.K. Frank, W.H. Kaye, C.C. Meltzer, J.C. Price, P. Greer, and C. McConaha Reduced 5-HT2A receptor binding after recovery from anorexia nervosa Biological Psychiatry 52 2002 896 906
9. D.A. Geller, J. Biederman, S.E. Stewart, B. Mullin, A. Martin, and T. Spencer Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder American Journal of Psychiatry 160 2003 1919 1928
10. German Scientific Society for Child and Adolescent Psychiatry and Psychotherapy. Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter 2003, Köln: Deutscher Ärzte Verlag, Germany
11. W.K. Goodman, L.H. Price, S.A. Rasmussen, C. Mazure, R.L. Fleischmann, and C.L. Hill The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability Archives of General Psychiatry 46 1989 1006 1011
12. U. Hagenah, V. Blume, M. Flacke-Redanz, and B. Herpertz-Dahlmann Psychological education as a group process for parents of adolescents with eating disorders Zeitschrift fur Kinder-und Jugendpsychiatrie und Psychotherapie 31 2003 51 58
13. Hazell P, O'Connell D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systematic Reviews 2002;(2):CD002317
14. J. Hebebrand, R. Casper, J. Treasure, and U. Schweiger The need to revise the diagnostic criteria for anorexia nervosa Journal of Neural Transmission 111 2004 827 840
15. B. Herpertz-Dahlmann, and H. Remschmidt Anorexia nervosa and depression: results of a longitudinal study H.C. Steinhausen Eating disorders in adolescence 1995 Walter de Gruyter Berlin, New York 127 144
16. M. Heer, C. Mika, I. Grzella, C. Drummer, and B. Herpertz-Dahlmann Changes in bone turnover in patients with anorexia nervosa during eleven weeks of inpatient dietary treatment Clinical Chemistry 48 2002 754 760
17. M. Heer, C. Mika, I. Grzella, N. Heussen, and B. Herpertz-Dahlmann Bone turnover during inpatient nutrtional treatment and outpatient follow-up in patients with anorexia nervosa compared to healthy controls American Journal of Clinical Nutrition 80 2004 779 787
18. B. Herpertz-Dahlmann, B. Muller, S. Herpertz, N. Heussen, J. Hebebrand, and H. Remschmidt Prospective 10-year follow-up in adolescent anorexia nervosa-course, outcome, psychiatric comorbidity, and psychosocial adaptation Journal of Child Psychology and Psychiatry 42 2001 603 612
19. J.N. Jureidini, C.J. Doecke, P.R. Mansfield, M.M. Haby, D.B. Menkes, and A.L. Tonkin Efficacy and safety of antidepressants for children and adolescents British Medical Journal 328 2004 879 883
20. E.A. Kastelic, M.J. Labellarte, and M.A. Riddle Selective serotonin reuptake inhibitors for children and adolescents Current Psychiatry Reports 2 2000 117 123
21. W.H. Kaye, H.E. Gwirtsman, D.T. George, and M.H. Ebert Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Archives of General Psychiatry 48 1991 556 562
22. W.H. Kaye, T.E. Weltzin, L.K. Hsu, and C.M. Bulik An open trial of fluoxetine in patients with anorexia nervosa Journal of Clinical Psychiatry 52 1991 464 471
23. W. Kaye, K. Gendall, and M. Strober Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa Biological Psychiatry 44 1998 825 838
24. W.H. Kaye, T. Nagata, T.E. Weltzin, L.K. Hsu, M.S. Sokol, and C. McConaha Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa Biological Psychiatry 49 2001 644 652
25. L.A. Kotler, M.J. Devlin, M. Davies, and B.T. Walsh An open trial of fluoxetine for adolescents with bulimia nervosa Journal of Child and Adolescent Psychopharmacology 13 2003 329 335
26. K. Kromeyer-Hauschild, M. Wabitsch, D. Kunze, F. Geller, H.C. Geiß, and V. Hesse Percentiles of body mass index in children and adolescents evaluated from different regional German studies Monatsschrift-Kinderheilkunde 149 2001 807 818
27. M.R. Liebowitz, S.M. Turner, J. Piacentini, D.C. Beidel, S.R. Clarvit, and S.O. Davies Fluoxetine in children and adolescents with OCD: a placebo-controlled trial Journal of the American Academy of Child and Adolescent Psychiatry 41 2002 1431 1438
28. J.E. Mitchell, M. de Zwaan, and J.L. Roerig Drug therapy for patients with eating disorders Current Drug Targets CNS Neurological Disorders 2 2003 17 29
29. P. Ramchandani Treatment of major depressive disorder in children and adolescents British Medical Journal 328 2004 3 4
30. N.D. Ryan Medication treatment for depression in children and adolescents CNS Spectroscopy 8 2003 283 287
31. P. Santonastaso, S. Friederici, and A. Favaro Sertraline in the treatment of restricting anorexia nervosa: an open controlled trial Journal of Child and Adolescent Psychopharmacology 11 2001 143 150
32. H.C. Steinhausen The outcome of anorexia nervosa in the 20th century American Journal of Psychiatry 159 2002 1284 1293
33. J. Stiensmeier-Pelster, M. Schürmann, and K. Duda Depressions-Inventar für Kinder und Jugendliche (DIKJ) 1989 Hogrefe Göttingen
34. M. Strober, R. Freeman, and W. Morrell The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study International Journal of Eating Disorders 22 1997 339 360
35. M. Strober, R. Freeman, M. DeAntonio, C. Lampert, and J. Diamond Does adjunctive fluoxetine influence the post-hospital course of restrictor-type anorexia nervosa? A 24-month prospective, longitudinal followup and comparison with historical controls Psychopharmacology Bulletin 33 1997 425 431
36. C.J. Whittington, T. Kendall, P. Fonagy, D. Cottrell, A. Cotgrove, and E. Boddington Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data The Lancet 363 2004 1341 1345
37. J.M. Zito, D.J. Safer, S. Dos Reis, J.F. Gardner, I. Magder, K. Soeken, M. Boles, F. Lynch, and M.A. Riddle Psychotropic practice patterns for youth: a 10-year perspective Archives of pediatrics & adolescent medicine 157 2003 17 25